PerkinElmer Banks on New Products to Drive 2006 Growth; Focus on Cell Analysis, Protein Biomarkers | GenomeWeb

PerkinElmer is hoping that a variety of life science research instruments it launched in 2005 will drive revenue in 2006 and help the firm meet its forecast of 5-percent to 7-percent organic growth this year.

Company officials said during a conference call last week that they expect the shift in the firm's product mix in 2005 to match the market's "migration of applications." Specifically, they believe PerkinElmer's growing focus on cell analysis and protein biomarkers should fuel revenue growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.